Evidence map›Paper›PMID 42904079›Full record

ArticleCentral European journal of urology2026

Prospective controlled

Marina Hoffmann, Benedikt Ebner, Nikolaos Pyrgidis, Iulia Blajan, Troya Georgieva, Marc Kidess, Moritz Happe, Yannic Volz, Lennert Eismann, Maria Apfelbeck and 2 more

Abstract read
In one paragraph

Article in Central European journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marina HoffmannDepartment of Urology, LMU Klinikum, Munich, Germany.
Benedikt EbnerDepartment of Urology, LMU Klinikum, Munich, Germany.
Nikolaos PyrgidisDepartment of Urology, LMU Klinikum, Munich, Germany.
Iulia BlajanDepartment of Urology, LMU Klinikum, Munich, Germany.
Troya GeorgievaDepartment of Urology, LMU Klinikum, Munich, Germany.
Marc KidessDepartment of Urology, LMU Klinikum, Munich, Germany.
Moritz HappeDepartment of Urology, LMU Klinikum, Munich, Germany.
Yannic VolzDepartment of Urology, LMU Klinikum, Munich, Germany.
Lennert EismannDepartment of Urology, LMU Klinikum, Munich, Germany.
Maria ApfelbeckDepartment of Urology, LMU Klinikum, Munich, Germany.
Christian G StiefDepartment of Urology, LMU Klinikum, Munich, Germany.
Michael ChaloupkaDepartment of Urology, LMU Klinikum, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ureteral stents significantly impair health-related quality of life. Advances in stent material, particularly in polyurethane compositions, may mitigate adverse effects. This study evaluated Material and methods: In this prospective controlled Results: Conclusions: Ureteral stents incorporating HybridPRO Technology demonstrated significantly greater elongation under standardized load after use compared to a control stent. These findings indicate material changes ex vivo; however, the clinical implications regarding comfort or quality of life remain to be determined in future studies.

Indexed as

biomaterialsmechanical propertiesstent designthermoplastic polyurethaneureteroscopy

Identifiers

PMID42904079
PMCPMC13681890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.